International experience with NORPLANT and NORPLANT-2 contraceptives.
Experience encompassing more than 20,000 woman-years of use of NORPLANT capsules and 6,000 woman-years of trials of NORPLANT-2 rods is reviewed. Implant contraception repeatedly has been associated with low pregnancy rates and high continuation rates through five full years of use. Weight has proved to be a factor related to effectiveness. Women weighing less than 50 kg experienced cumulative five-year pregnancy rates well below 1 per 100, whereas the overall cumulative rate has been 3.5 per 100. Medical events reported during use that have led to discontinuation are analyzed from four large data sets.
D001835:Body Weight; D005260:Female; D006454:Hemoglobins; D006801:Humans; D016912:Levonorgestrel; D008599:Menstruation Disturbances / Q000139:chemically induced; D009644:Norgestrel / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D010349:Patient Compliance; D011247:Pregnancy
D006454:Hemoglobins; D009644:Norgestrel; D016912:Levonorgestrel